Correction: Alternative mammalian target of rapamycin (mTOR) signal activation in sorafenib-resistant hepatocellular carcinoma cells revealed by array-based pathway profiling.

Ítems similars

• Alternative Mammalian Target of Rapamycin (mTOR) Signal Activation in Sorafenib-resistant Hepatocellular Carcinoma Cells Revealed by Array-based Pathway Profiling
  per: Masuda, Mari, et al.
  Publicat: (2014)
• The mTOR (Mammalian Target of Rapamycin) Kinase Maintains Integrity of mTOR Complex 2
  per: Chen, Chien-Hung, et al.
  Publicat: (2011)
• Rapamycin and mTOR kinase inhibitors
  per: Ballou, Lisa M., et al.
  Publicat: (2008)
• Inhibition of the Mechanistic Target of Rapamycin (mTOR)–Rapamycin and Beyond
  per: Lamming, Dudley W.
  Publicat: (2016)
• Biomarker Discovery of Pancreatic and Gastrointestinal Cancer by 2DICAL: 2-Dimensional Image-Converted Analysis of Liquid Chromatography and Mass Spectrometry
  per: Ono, Masaya, et al.
  Publicat: (2012)